TokenPost·

Jaguar Health Targets Mid-2027 MVID Filing After More Than $10 Million in Debt Reduction

Your call?

Participants in the pivotal pediatric MVID trial have entered extension dosing. Jaguar also plans to seek breakthrough therapy designation in 2027.

Share

More news